Next Generation Sequencing (NGS) Market By Product {Consumables (DNA Fragmentation, End Repair, A-Tailing and Size Selection, Library Preparation & Target Enrichment, Quality Control) Platforms (HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II and Sequel System) , and Services (Sequencing Services and Data Management Services)}, By Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, and Others), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Others), By End User (Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Others), and by Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) — Industry Trends and Forecast to 2032

The Global Next Generation Sequencing Market (NGS) has been valued at USD 7.67 Billion in 2022 and is projected to grow at a CAGR of 19.32% during the forecast period from 2023-2032. Next generation sequencing (NGS) is an evolving technology in which methods have been developed for genomic sequences analysis. Next-generation sequencing (NGS) is also called second-generation sequencing. It has enabled sequencing of many samples simultaneously at an extraordinary speed. It has helped in achieving significant progress in life sciences research and clinical diagnostics.

NGS is used for understanding the link between genetics and diseases. Research institutes are using it to diagnose and treat cancer, rare diseases, and other conditions. Increasing application of NGS in medicine is driving the growth of the global market for next generation sequencing. The use of emerging technologies, such as cloud storage with NGS has enabled researchers to handle sizable data and analysis, which is driving the growth of the market.

Genome sequencing has helped to understand the spread of Covid-19, and it will help in discovering treatment for the same in the future. For instance, in March 2020, Covid-19 Genomics U.K. Consortium (COG-U.K.) assisted to analyse the coronavirus genome. The entity was formed to assist in understanding the disease using whole-genome sequencing (WGS).

The on-going COVID-19 pandemic has led to significant social and economic losses. Next generation sequencing technologies have been used to reconstruct the genomic sequence of SARS-CoV-2. It has helped in deriving diagnostic solutions through diagnostic molecular test and in minimizing the spread of the disease. As a result, the next generation sequencing market is expected to grow rapidly over the forecast period.  

                     TABLE 1: GLOBAL NEXT GENERATION SEQUENCING MARKET OVERALL SNAPSHOT

Table 1

FIGURE 1: GLOBAL NEXT GENERATION SEQUENCING MARKET SEGMENTATION

Fig 1

Next Generation Sequencing market, by Product

Based on product, the market for next generation sequencing is divided into consumables, platforms, and services. The consumables segment is expected to grow during the forecast period. Consumables are required to execute sample preparation processes, which is driving the segment's growth. It also helps in sorting samples to speed up the process and improve the quality of the data obtained. This is expected to drive the growth of the segment during the forecast period.

Next Generation Sequencing Market, by Application

Based on applications, the market for next generation sequencing is divided into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, agriculture and animal research, and other applications. The diagnostics segment is expected to grow significantly during the forecast period. Next generation sequencing has enabled the sequencing of a large volume of genomic data. NGS is used in clinical diagnosis for diagnosing hereditary disorders, as it is known for analytic accuracy, high throughput, and potential cost-effectiveness. This, in turn, is expected to drive the growth of the segment.

Next Generation Sequencing Market, by Technology

Based on technology, the market for next generation sequencing is divided into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, and other technologies. The sequencing by synthesis segment is expected to grow during the forecast period. Sequencing by synthesis is a highly accurate sequencing that eliminates errors and is the most widely adopted NGS technology. It is capturing a major share of the global sequencing data.

Next Generation Sequencing Market, by End User

Based on the end-user, the market for next generation sequencing is divided into academic and clinical research centers, pharmaceutical and biotechnology companies, hospitals and clinics, and others. The pharmaceutical and biotechnology companies segment is expected to grow during the forecast period. Pharmaceutical and biotechnology companies are using next generation sequencing technology (NGS) to revolutionize biological sciences. It has enabled researchers to perform a wide variety of applications and study biological systems acutely by becoming an important tool for decoding complex genomic research.

Next Generation Sequencing Market, by Region

Based on regions, the global next generation sequencing market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South America. The market in North America is expected to witness considerable growth during the forecast period. Increasing R&D initiatives for drug development and disease prevention enabled by next generation sequencing are driving the growth of the market. Increasing use of NGS for genetic testing in diagnostics is also driving the growth of the market.

The market in the Asian Pacific region is expected to grow significantly over the forecast period. Increasing efforts by government bodies and key market players to promote NGS services for disease detection and prevention are driving the growth of this regional market.

TABLE 2: GLOBAL NEXT GENERATION SEQUENCING MARKET OVERVIEWTable 2

FIGURE 2: GLOBAL NEXT GENERATION SEQUENCING MARKET (USD MILLION), 2021-2030

fig 2

Recent Developments in the Global Next Generation Sequencing Market

  • May, 2021 - Bio-Rad Laboratories, Inc. announced the launch of SEQuoia RiboDepletion kit. The new product improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library.
  • April, 2021 - Biodesix, Inc. announced their plan to add a blood-based 52-gene next generation sequencing (NGS) test to their portfolio of molecular testing.
  • April, 2021 - Illumina pledged USD 60 million in genomic sequencing expertise to help launch a global outbreak-tracking network. The company has collaborated with the Bill & Melinda Gates Foundation and other public and private groups. The aim of the collaboration is to help identify pathogens as early as possible and alert the rest of the world to emerging epidemics.
  • January, 2021 - Crown Bioscience announced the launch of proprietary NGS panel services, providing increased opportunities for pharmaceutical partners to better understand drug mechanisms of action (MOA). It will also help them in developing predictive biomarkers for their investigational drug candidates.
  • September, 2020 - BioReference Laboratories, Inc. announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples.
  • August, 2020 - Ancestry, a global leader in consumer genomics, announced the launch of AncestryHealth powered by next generation sequencing (NGS). It is designed to help people understand their risk for developing certain inheritable health conditions. The new product offers advanced testing technology and provides comprehensive genetic screening for health conditions.

What Does This Report Provide?

This report provides a detailed understanding of the global next generation sequencing market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

The major market drivers, challenges, and opportunities for the global next generation sequencing market have been covered in the report. This report further includes the market shares of the leading companies operating in the global market, along with their production capacities and the growth strategies adopted by them.

Market Segmentation:

By Product

  • Consumables
    • Sample Preparation Consumables
  • DNA Fragmentation, End Repair, A-Tailing and Size Selection
  • Library Preparation & Target Enrichment
  • Quality Control
    • Other Consumables
  • Platforms
    • HiSeq
    • MiSeq
    • Ion Torrent
    • SOLiD
    • Pacbio Rs II and Sequel System
    • Other Sequencing Platforms
  • Services
    • Sequencing Services
  • RNA Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Targeted Sequencing
  • Chip Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
    • Data Management Services
  • NGS Data Analysis Services
  • NGS Data Analysis Software & Workbenches
  • NGS Storage, Management and Cloud Computing Solutions

By Application

  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Agriculture & Animal Research
  • Others

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Others

By End User

  • Academic and Clinical Research Centers
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Others

By Region:

North America Next Generation Sequencing Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Product
  • North America, by Application
  • North America, by Technology
  • North America, by End User

Europe Next Generation Sequencing Market

  • Europe, by Country
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe 
  • Europe, by Product
  • Europe, by Application
  • Europe, by Technology
  • Europe, by End User

Asia Pacific Next Generation Sequencing Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific 
  • Asia Pacific, by Product
  • Asia Pacific, by Application
  • Asia Pacific, by Technology
  • Asia Pacific, by End User

Middle East and Africa Next Generation Sequencing Market

  • Middle East and Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East and Africa
  • Middle East and Africa, by Product
  • Middle East and Africa, by Application
  • Middle East and Africa, by Technology
  • Middle East and Africa, by End User

South America Next Generation Sequencing Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Rest of South America
  • South America, by Product
  • South America, by Application
  • South America, by Technology
  • South America, by End User

Major Companies: The major companies studied in this report include : Illumina Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., Roche Holding AG, Agilent Technologies, Inc., Perkinelmer, Inc., Genomatix GmbH, and PierianDx, Eurofins Scientific, Gatc Biotech AG, Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., DNASTAR, Inc., Biomatters Ltd., Partek Inc., New England Biolabs, Inc. and Myriad Genetics, Inc.

Objectives of This Report:

  • To estimate the market size for the next generation sequencing market on a regional and global basis.
  • To identify major segments in the next generation sequencing market and evaluate their market shares and demand.
  • To provide the competitive scenario for the next generation sequencing market with major developments observed by the key companies in the historic years.
  • To evaluate the key factors governing the dynamics of next generation sequencing market with their potential gravity during the forecast period.
  • To evaluate the leading company-wise pricing analysis for the mentioned applications.

Key Questioned Answered in the Study:

  • What are major growth drivers and market trends that are affecting the global next generation sequencing market?
  • What is the market size in terms of both value and volume for the global next generation sequencing market?
  • Who are the leading market players and who are the new market players that operate in the global next generation sequencing market with an estimated market share?
  • What are the future investment pockets and opportunities in the global next generation sequencing market?
  • Major list of customers and potential futuristic customer list along with an estimated buying volume.
  • What will be the impact of COVID-19 on the global next generation sequencing market?

Customization:

This study is customized to meet your specific requirements:

  • By sub-segment
  • By client-specific country, type, and application market analysis
  • Pricing analysis along with the potential list of customers
  • Product-specific competitive analysis

For more information, contact: sales@quincemarketinsights.com